Wayne, your World sends me the signal of a very special thinking you have, -brilliant!Rogues World is thinking in terms of “put or call options” to be struck with a number of the examples that come to your mind.
A pharma loaded with the orphan development investment you allude to may well jump at the opportunity to enter into a contract whereby when PYC prove the cell entry for their development we excercise our put option and rights to our IP, or make a call option that then triggers our obligation and rights to their technology.
The terms of the options proposed may be eye watering to the Pharma, however it may appeal as a neat prospect of getting their drug cargoes into the cells they seek.
I’m sure Rohan would be interested to have your thoughts on the examples you have in mind. GLTA
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.040(3.23%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.28 | $1.25 | $71.05K | 56.40K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 444 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 28000 | 1 |
View Market Depth
| Last trade - 13.48pm 25/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |